PAR PHARM FDA Approval ANDA 088961

ANDA 088961

PAR PHARM

FDA Drug Application

Application #088961

Application Sponsors

ANDA 088961PAR PHARM

Marketing Status

Discontinued001

Application Products

001CAPSULE;ORAL100MG;50MG0HYDRA-ZIDEHYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE

FDA Submissions

ORIG1AP1985-10-21
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1988-05-02
LABELING; LabelingSUPPL10AP1988-11-29
LABELING; LabelingSUPPL11AP1989-01-26
LABELING; LabelingSUPPL12AP1989-05-08
LABELING; LabelingSUPPL14AP1991-04-04
LABELING; LabelingSUPPL15AP1991-06-14
LABELING; LabelingSUPPL16AP1995-02-03
MANUF (CMC); Manufacturing (CMC)SUPPL17AP1997-11-26
MANUF (CMC); Manufacturing (CMC)SUPPL18AP1997-11-26
LABELING; LabelingSUPPL22AP2020-08-20STANDARD

Submissions Property Types

SUPPL7Null0
SUPPL17Null0
SUPPL18Null0
SUPPL22Null15

CDER Filings

STRIDES PHARMA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 88961
            [companyName] => STRIDES PHARMA
            [docInserts] => ["",""]
            [products] => [{"drugName":"HYDRA-ZIDE","activeIngredients":"HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE","strength":"100MG;50MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"HYDRA-ZIDE","submission":"HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE","actionType":"100MG;50MG","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.